Daiwa Securities Group’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Daiwa Securities Group’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-56	Closed	-$3K	–	1308
2021 Q1	$3K	Hold	56	–	–	﹤0.01%	1130
2020 Q4	$1K	Buy	+56	New	+$779	﹤0.01%	1250

Daiwa Securities Group's PAND Position: Q2 2021 in Review

Daiwa Securities Group sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 56 shares — an estimated $3K sold.

Daiwa Securities Group first reported a position in PAND in Q4 2020 and held it in 2 quarters. The position peaked at $3K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Daiwa Securities Group reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Daiwa Securities Group sold 56 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $3K.
Daiwa Securities Group first reported a position in Pandion Therapeutics Inc. Common Stock in Q4 2020 and held it in 2 quarters.
Daiwa Securities Group's Pandion Therapeutics Inc. Common Stock position peaked at $3K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Daiwa Securities Group's 13F filing for Q2 2021, filed 6 Aug 2021.